StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research note published on Wednesday. The brokerage issued a hold rating on the stock.

China Pharma Stock Down 12.7 %

China Pharma stock opened at $0.37 on Wednesday. The stock’s 50 day moving average is $0.42 and its 200 day moving average is $0.52. The company has a quick ratio of 0.29, a current ratio of 0.82 and a debt-to-equity ratio of 0.23. China Pharma has a one year low of $0.32 and a one year high of $2.70.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Articles

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.